Literature DB >> 10705891

Gatifloxacin and moxifloxacin: two new fluoroquinolones.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10705891

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN： 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  4 in total

1.  Moxifloxacin versus levofloxacin or ciprofloxacin prophylaxis in acute myeloid leukemia patients receiving chemotherapy.

Authors:  Daniel J Przybylski; David J Reeves
Journal:  Support Care Cancer       Date:  2017-06-28       Impact factor: 3.603

Review 2.  A critical review of the fluoroquinolones: focus on respiratory infections.

Authors:  George G Zhanel; Kelly Ennis; Lavern Vercaigne; Andrew Walkty; Alfred S Gin; John Embil; Heather Smith; Daryl J Hoban
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Drugs in development for tuberculosis.

Authors:  Ann M Ginsberg
Journal:  Drugs       Date:  2010-12-03       Impact factor: 9.546

4.  Comparative evaluation of aqueous and plasma concentration of topical moxifloxacin alone and with flurbiprofen in patients of cataract surgery.

Authors:  Sujash Halder; Kanchan Kumar Mondal; Supreeti Biswas; Tapan Kumar Mandal; Bakul Kumar Dutta; Mithilesh Haldar
Journal:  Indian J Pharmacol       Date:  2013 May-Jun       Impact factor: 1.200
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.